PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

51 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
1.
Buschulte, K.* et al.: Hospitalisation patterns in interstitial lung diseases: Data from the EXCITING-ILD registry. Respir. Res. 25:5 (2024)
2.
Buschulte, K.* et al.: Disease trajectories in interstitial lung diseases - data from the EXCITING-ILD registry. Respir. Res. 25:113 (2024)
3.
Upadhyay, S.* et al.: Assessment of wood smoke induced pulmonary toxicity in normal- and chronic bronchitis-like bronchial and alveolar lung mucosa models at air-liquid interface. Respir. Res. 25:49 (2024)
4.
Pouwels, S.D.* et al.: Smoking increases expression of the SARS-CoV-2 spike protein-binding long ACE2 isoform in bronchial epithelium. Respir. Res. 24:130 (2023)
5.
Staude, B.* et al.: Microbial signatures in amniotic fluid at preterm birth and association with bronchopulmonary dysplasia. Respir. Res. 24:248 (2023)
6.
Kreuter, M.* et al.: Epidemiology, healthcare utilization, and related costs among patients with IPF: Results from a German claims database analysis. Respir. Res. 23:62 (2022)
7.
Marijic, P. et al.: Comparing outcomes of ILD patients managed in specialised versus non-specialised centres. Respir. Res. 23:220 (2022)
8.
Nikolova, S.* et al.: Correction to: Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis. Respir. Res. 23:2 (2022)
9.
van der Does, A.M.* et al.: Early transcriptional responses of bronchial epithelial cells to whole cigarette smoke mirror those of in-vivo exposed human bronchial mucosa. Respir. Res. 23:227 (2022)
10.
Huber, M.B. et al.: Long-term weight gain in obese COPD patients participating in a disease management program: A risk factor for reduced health-related quality of life. Respir. Res. 22:226 (2021)
11.
Kellerer, C.* et al.: Prediction of lung emphysema in COPD by spirometry and clinical symptoms: Results from COSYCONET. Respir. Res. 22:242 (2021)
12.
Maqhuzu, P.N. et al.: Cost drivers in the pharmacological treatment of interstitial lung disease. Respir. Res. 22:218 (2021)
13.
Marijic, P. et al.: Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: A retrospective cohort study. Respir. Res. 22:268 (2021)
14.
Huber, M.B. et al.: The relationship between body mass index and health-related quality of life in COPD: Real-world evidence based on claims and survey data. Respir. Res. 21:291 (2020)
15.
Kahnert, K.* et al.: The impact of COPD on polyneuropathy: Results from the German COPD cohort COSYCONET. Respir. Res. 21:28 (2020)
16.
Veit, T. et al.: Variability of forced vital capacity in progressive interstitial lung disease: A prospective observational study. Respir. Res. 21:270 (2020)
17.
Wälscher, J.* ; Witt, S. ; Schwarzkopf, L. & Kreuter, M.*: Hospitalisation patterns of patients with interstitial lung disease in the light of comorbidities and medical treatment - a German claims data analysis. Respir. Res. 21:73 (2020)
18.
Flexeder, C. et al.: Second-hand smoke exposure in adulthood and lower respiratory health during 20 year follow up in the European Community Respiratory Health Survey. Respir. Res. 20:33 (2019)
19.
Kirsch, F. et al.: Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: Results from the LQ-DMP study. Respir. Res. 20:215 (2019)
20.
von Siemens, S.M. et al.: Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: Results from the COSYCONET cohort study. Respir. Res. 20:30 (2019)
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮